Skip to main content
Premium Trial:

Request an Annual Quote

Germany to Increase Viral Sequencing

Germany plans to boost its SARS-CoV-2 sequencing efforts, according to Reuters.

It adds that other countries like the UK and Denmark have robust coronavirus sequencing operations. The UK, for instance, began sequencing SARS-CoV-2 samples early in the pandemic through its COVID-19 Genomics UK consortium, and, last month, spotted a new variant that appears to be more easily transmitted.

A new draft order from the German Health Ministry would now require that 5 percent of patient samples that test positive for SARS-CoV-2 be sent for sequencing, Reuters reports, noting that the UK sequences between 5 percent and 10 percent of its positive samples. It adds that Germany would further provide laboratories €200 (US $243) for each sample sequenced.

"The 5 percent strike rate is quite doable," Evangelos Kotsopoulos, a board member of ALM, association of German diagnostic labs, tells Reuters. "The capacity is there, the equipment is there, the people are there."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.